Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Payables (2022 - 2025)

Jin Medical International (ZJYL) has disclosed Payables for 4 consecutive years, with $19.0 million as the latest value for Q3 2025.

  • Quarterly Payables rose 32.68% to $19.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $19.0 million through Sep 2025, up 32.68% year-over-year, with the annual reading at $19.0 million for FY2025, 32.68% up from the prior year.
  • Payables hit $19.0 million in Q3 2025 for Jin Medical International, up from $14.3 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $19.0 million in Q3 2025 to a low of $393760.0 in Q3 2022.
  • Historically, Payables has averaged $10.3 million across 4 years, with a median of $10.9 million in 2023.
  • Biggest five-year swings in Payables: skyrocketed 1805.75% in 2023 and later surged 32.68% in 2025.
  • Year by year, Payables stood at $393760.0 in 2022, then surged by 1805.75% to $7.5 million in 2023, then soared by 91.03% to $14.3 million in 2024, then soared by 32.68% to $19.0 million in 2025.
  • Business Quant data shows Payables for ZJYL at $19.0 million in Q3 2025, $14.3 million in Q3 2024, and $7.5 million in Q3 2023.